A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse modelJesus Campagna, Varghese John, Asa Hatami et al.|Scientific Reports|2018Cited by 36